🇺🇸 TRIPTORELIN in United States

1,659 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 310 reports (18.69%)
  2. Death — 302 reports (18.2%)
  3. Ovarian Hyperstimulation Syndrome — 240 reports (14.47%)
  4. Disease Progression — 193 reports (11.63%)
  5. Asthenia — 107 reports (6.45%)
  6. Dementia Alzheimer^S Type — 106 reports (6.39%)
  7. Malignant Neoplasm Progression — 106 reports (6.39%)
  8. Anaemia — 105 reports (6.33%)
  9. Fatigue — 96 reports (5.79%)
  10. Nausea — 94 reports (5.67%)

Source database →

TRIPTORELIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TRIPTORELIN approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for TRIPTORELIN in United States?

Marketing authorisation holder not available in our data.